Skip to content

    Recently Viewed

      Listening...

      FINAL LEDE- Johnson & Johnson Named a LinkedIn Top Company for 2019- LinkedIn Top Companies

      Johnson & Johnson named a LinkedIn Top Company for 2019

      The LinkedIn list recognizes companies in the U.S. where people most want to work. And this year, Johnson & Johnson is also featured on the Brazil, Japan and UK lists.

      Share Article
      share to

      Johnson & Johnson not only strives to provide its employees with industry-leading benefits—such as global parental leave and military leave—but it’s also working to have the world’s healthiest workforce by offering its employees access to programs and services that support personal well-being.

      These efforts received special recognition today, when Johnson & Johnson was named to LinkedIn’s Top Companies list, which honors the 50 most sought-after companies to work for nationwide—places where people want to not only work today, but stay into the future.

      Inset- Johnson & Johnson Named a LinkedIn Top Company for 2019- LinkedIn Top Companies Logo

      The Top Companies list was launched in 2016 to celebrate the organizations making an impact in the work world—and help LinkedIn users consider where they may want to land their next job.

      To select the winners, LinkedIn measures the behavior of over a half-billion professionals on its site to give corporations a blended score, focused on four core areas: interest in a company, engagement with employees, job interest and retention. In essence, LinkedIn members cast a “vote” through their interactions on the site.

      In addition to making the U.S. list this year, Johnson & Johnson is also proud to announce that it has been named to the Top Companies lists in Brazil, Japan and the UK.

      More from Johnson & Johnson

      Innovation
      Two cardiac electrophysiologists performing a cardiac ablation procedure to treat AFib

      What is cardiac ablation?

      For American Heart Month, learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.
      Latest news
       Biomedical scientist Robert Langer headshot

      Biomedical scientist Robert Langer receives the 2023 Dr. Paul Janssen Award for Biomedical Research

      Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health.
      Health & wellness
       Blue latex gloved hand pointing at a brain MRI scan to pinpoint brain circuits associated with depression symptoms

      Is this the end of one-size-fits-all treatments for depression?

      Johnson & Johnson is working to bring personalized psychiatry to the 7 in 10 people with depression whose treatments aren’t getting the job done.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.